US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Verve Therapeutics

5.14

-0.0550-1.06%

Volume:709.70K

Turnover:3.63M

Market Cap:455.97M

PE:-2.19

High:5.26

Open:5.14

Low:4.99

Close:5.19

Loading ...

Overview Company News Filings

Verve Therapeutics Surges Premarket on Verve-102 Study Data

Buy Rating for Verve Therapeutics: Promising Safety and Efficacy of VERVE-102 in Phase 1b Heart-2 Study

Verve announces initial data from Heart-2 Phase 1b trial of VERVE-102

Verve Therapeutics- Verve-102, No Clinically Significant Changes in Alt or Platelets Observed at Any Dose Level Among 14 Participants

THOMSON REUTERS

Verve Therapeutics Announces Positive Initial Data from the Heart-2 Phase 1b Clinical Trial of VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9

Verve Therapeutics Gets FDA Fast Track Designation for VERVE-102

MT Newswires Live

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Biotech stocks slide as Marks resignation seen being negative for sector

Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors

THOMSON REUTERS

Verve Therapeutics Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Positive Outlook for Verve Therapeutics: Buy Rating Backed by FDA Clearance and Promising Developments

Positive Outlook for Verve Therapeutics: Buy Rating Driven by Promising VERVE-102 Trial Data and Design Improvements

Verve Therapeutics Says US FDA Clears Verve-102 IND Application for Premature Coronary Artery Disease

MT Newswires Live

Verve Therapeutics Announces Clearance of Investigational New Drug Application by the U.S. FDA for Verve-102, an Investigational Gene Editing Medicine Designed to Durably Lower Cholesterol After a Single Dose

THOMSON REUTERS

Verve Therapeutics Announces Clearance of Investigational New Drug Application by the U.S. FDA for VERVE-102, an Investigational Gene Editing Medicine Designed to Durably Lower Cholesterol After a Single Dose

Verve Therapeutics Is Maintained at Outperform by RBC Capital

Verve Therapeutics price target lowered to $15 from $17 at RBC Capital

RBC Cuts Price Target on Verve Therapeutics to $15 From $17, Keeps Outperform, Speculative Risk

MT Newswires Live

RBC Capital Keeps Their Buy Rating on Verve Therapeutics (VERV)

Verve Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/VERV/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VERV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VERV\",,,,,undefined,":{"symbol":"VERV","market":"US","secType":"STK","nameCN":"Verve Therapeutics","latestPrice":5.135,"timestamp":1746459821837,"preClose":5.19,"halted":0,"volume":709695,"delay":0,"floatShares":64970931,"shares":88795768,"eps":-2.345416,"marketStatus":"Trading","change":-0.055,"latestTime":"05-05 11:43:42 EDT","open":5.14,"high":5.26,"low":4.99,"amount":3629332.396557,"amplitude":0.052023,"askPrice":5.14,"askSize":368,"bidPrice":5.13,"bidSize":1104,"shortable":3,"etf":0,"ttmEps":-2.345416,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746475200000},"marketStatusCode":2,"adr":0,"listingDate":1623902400000,"exchange":"NASDAQ","adjPreClose":5.19,"preHourTrading":{"tag":"盘前","latestPrice":5.2,"preClose":5.19,"latestTime":"09:28 EDT","volume":15688,"amount":82124.7299816,"timestamp":1746451710112},"postHourTrading":{"tag":"盘后","latestPrice":5.27,"preClose":5.19,"latestTime":"19:52 EDT","volume":81579,"amount":430100.9961,"timestamp":1746229951629},"volumeRatio":0.890403,"impliedVol":0.2859,"impliedVolPercentile":0.064},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VERV\",,,,,undefined,":{"symbol":"VERV","floatShares":64970931,"roa":"-20.41%","roe":"-36.36%","lyrEps":-2.345416,"volumeRatio":0.890403,"shares":88795768,"dividePrice":0,"high":5.26,"amplitude":0.052023,"preClose":5.19,"low":4.99,"week52Low":2.8647,"pbRate":"0.92","psRate":"14.10","week52High":9.305,"institutionHeld":0,"latestPrice":5.135,"committee":0.5,"eps":-2.345416,"divideRate":0,"volume":709695,"delay":0,"ttmEps":-2.345416,"open":5.14,"prevYearClose":5.64,"prevWeekClose":5.19,"prevMonthClose":5.67,"prevQuarterClose":4.57,"fiveDayClose":5.73,"twentyDayClose":3.62,"sixtyDayClose":8.36},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VERV\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2527773152","title":"Verve Therapeutics Surges Premarket on Verve-102 Study Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2527773152","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527773152?lang=en_us&edition=fundamental","pubTime":"2025-04-14 20:08","pubTimestamp":1744632480,"startTime":"0","endTime":"0","summary":"Verve Therapeutics shares rose sharply in premarket trading Monday after the clinical-stage genetic-medicines company reported positive early study data for its Verve-102 gene-editing drug targeting a cholesterol driver of atherosclerosis.Shares of the Boston company, which closed Friday at $3.26, were recently up 45% to $4.74.Verve-102 is designed to be a single-course treatment that permanently turns off the PCSK9 gene in the liver and durably reduces low-density lipoprotein cholesterol, or LDL-C.Verve said a single infusion of Verve-102 led to dose-dependent decreases in blood PCSK9 protein levels and LDL-C, with a mean reduction in blood LDL-C of 53% and a maximum LDL-C reduction of 69% observed among four participants in the 0.6 mg/kg dose cohort.Verve on Friday said the U.S. Food and Drug Administration granted fast-track designation to Verve-102.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VERV","BK4539","BK4139"],"gpt_icon":0},{"id":"2527154874","title":"Buy Rating for Verve Therapeutics: Promising Safety and Efficacy of VERVE-102 in Phase 1b Heart-2 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2527154874","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527154874?lang=en_us&edition=fundamental","pubTime":"2025-04-14 19:45","pubTimestamp":1744631137,"startTime":"0","endTime":"0","summary":"Verve Therapeutics (VERV – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Cory Jubinville, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-for-verve-therapeutics-promising-safety-and-efficacy-of-verve-102-in-phase-1b-heart-2-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-for-verve-therapeutics-promising-safety-and-efficacy-of-verve-102-in-phase-1b-heart-2-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VERV"],"gpt_icon":0},{"id":"2527045153","title":"Verve announces initial data from Heart-2 Phase 1b trial of VERVE-102","url":"https://stock-news.laohu8.com/highlight/detail?id=2527045153","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527045153?lang=en_us&edition=fundamental","pubTime":"2025-04-14 19:11","pubTimestamp":1744629103,"startTime":"0","endTime":"0","summary":"Verve Therapeutics (VERV) announced initial data from the Heart-2 Phase 1b clinical trial of VERVE-102. The Heart-2 Phase 1b clinical trial is eval...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/verve-announces-initial-data-from-heart-2-phase-1b-trial-of-verve-102?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/verve-announces-initial-data-from-heart-2-phase-1b-trial-of-verve-102?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","VERV"],"gpt_icon":0},{"id":"2527563158","title":"Verve Therapeutics- Verve-102, No Clinically Significant Changes in Alt or Platelets Observed at Any Dose Level Among 14 Participants","url":"https://stock-news.laohu8.com/highlight/detail?id=2527563158","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527563158?lang=en_us&edition=fundamental","pubTime":"2025-04-14 19:00","pubTimestamp":1744628409,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nFWN3QQ054:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VERV","BK4539","BK4139"],"gpt_icon":0},{"id":"2527533581","title":"Verve Therapeutics Announces Positive Initial Data from the Heart-2 Phase 1b Clinical Trial of VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9","url":"https://stock-news.laohu8.com/highlight/detail?id=2527533581","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527533581?lang=en_us&edition=fundamental","pubTime":"2025-04-14 19:00","pubTimestamp":1744628400,"startTime":"0","endTime":"0","summary":"Single infusion of VERVE-102 led to dose-dependent decreases in blood PCSK9 and LDL-C, with mean reduction in LDL-C of 53% and a maximum reduction of 69% observed in the 0.6 mg/kg dose cohort VERVE-10","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/14/3060774/0/en/Verve-Therapeutics-Announces-Positive-Initial-Data-from-the-Heart-2-Phase-1b-Clinical-Trial-of-VERVE-102-an-In-Vivo-Base-Editing-Medicine-Targeting-PCSK9.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNA","VERV","BK4539","ALT","BK4599","LU1169589451.USD","BK4505","PD","BK4023","BK4585","BK4588","LU1169590202.USD","BK4139","LU1878469433.USD"],"gpt_icon":0},{"id":"2526668852","title":"Verve Therapeutics Gets FDA Fast Track Designation for VERVE-102","url":"https://stock-news.laohu8.com/highlight/detail?id=2526668852","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526668852?lang=en_us&edition=fundamental","pubTime":"2025-04-11 19:40","pubTimestamp":1744371630,"startTime":"0","endTime":"0","summary":"Verve Therapeutics  said Friday the US Food and Drug Administration granted fast track designation for its experimental VERVE-102 treatment for hyperlipidemia and high lifetime cardiovascular risk to lower low-density lipoprotein cholesterol.The company is testing VERVE-102 in a phase 1b clinical trial. The study's demographic and initial safety and efficacy data are expected in Q2.Verve Therapeutics shares were up 4.9% in recent premarket activity.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","IE00BFXG0V08.USD","BK4139","VERV","BK4104","FAST","BK4539","IE00B5TLWC47.USD","IE00BYQQ9H92.USD","BK4588","BK4567"],"gpt_icon":0},{"id":"2525499737","title":"Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2525499737","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525499737?lang=en_us&edition=fundamental","pubTime":"2025-04-05 04:05","pubTimestamp":1743797100,"startTime":"0","endTime":"0","summary":"BOSTON, April  04, 2025  (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on March 31, 2025","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/04/3056189/0/en/Verve-Therapeutics-Announces-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","BK4139","MNQmain","SQQQ","BK4112",".IXIC","QID","TSYW.SI","USJW.SI","BK4588","IE00B3QW5Z07.USD","BK4539","IE00B64PRP62.GBP","NDAQ","VERV","LU2095319765.USD","BK4585","NVIW.SI","LU2210149790.SGD","QLD","PSQ","TQQQ","LU2210150020.SGD","USAW.SI","IE00BGHQF748.EUR","NQmain"],"gpt_icon":1},{"id":"2524491531","title":"Biotech stocks slide as Marks resignation seen being negative for sector","url":"https://stock-news.laohu8.com/highlight/detail?id=2524491531","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524491531?lang=en_us&edition=fundamental","pubTime":"2025-04-01 23:50","pubTimestamp":1743522637,"startTime":"0","endTime":"0","summary":"Shares of several biotech and biopharma names are under pressure on Monday following the resignation of the head of the Food and Drug Administration’s Center for Biologics Evaluation and Research, Peter Marks. RBC Capital says the development is “not good for the biotech industry even beyond vaccines.” Voicing a similar opinion, BMO Capital told investors this morning that it sees the news as a “significant negative” for the biopharma and biotech sectors.Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks.“NOT GOOD” FOR BIOTECH SECTOR: RBC Capital believes the resignation of the head of the FDA’s Center for Biologics Evaluation and Research, Peter Marks, is “not good for the biotech industry even beyond vaccines.” Marks had been a key advocate for more flexible, efficient approval processes for drugs, particularly those for orphan diseases such as gene therapies, the firm tells investors in a research note.PRICE ACTION: In mornin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/biotech-stocks-slide-marks-resignation-155037694.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biotech-stocks-slide-marks-resignation-155037694.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SRPT","LU0058720904.USD","LU2468319806.SGD","NTLA","LU1066053197.SGD","IE00B3T34201.USD","BEAM","LU2023250504.SGD","LU0417517546.SGD","GLPG","LU0823416689.USD","LU1066051498.USD","RNA","LU1430594728.SGD","VERV","REGN","VRTX","RGNX","BK4532","LU2462157665.USD","LU1035775433.USD","BK4139","BK4568","PTCT","CRSP","MRNA","IE00BFTCPJ56.SGD","IE0002141913.USD","GILD","FDMT","BK4551","BK4007","BK4578","LU1571399168.USD","PCRX","LU2362540622.SGD","RCKT","LU1069344957.HKD","IE0009355771.USD","NGNE","RCKTW","DYN","IE00BZ9MQY76.HKD","DTIL","PRME","IE00B4R5TH58.HKD","KPTI","LU0320765992.SGD","MGTX","MGX","LEGN","TSHA"],"gpt_icon":1},{"id":"2524191062","title":"Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2524191062","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524191062?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:00","pubTimestamp":1743505202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nTUA7FW8VJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","ABOS","BK4139","SLDB","VERV","BK7067","BK7508","IMU.AU","LENZ","CLYM"],"gpt_icon":0},{"id":"2522577026","title":"Verve Therapeutics Price Target Maintained With a $15.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2522577026","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522577026?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:25","pubTimestamp":1742901900,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VERV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 25, 2025 07:25 ET (11:25 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VERV"],"gpt_icon":0},{"id":"2522402368","title":"Positive Outlook for Verve Therapeutics: Buy Rating Backed by FDA Clearance and Promising Developments","url":"https://stock-news.laohu8.com/highlight/detail?id=2522402368","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522402368?lang=en_us&edition=fundamental","pubTime":"2025-03-25 18:45","pubTimestamp":1742899537,"startTime":"0","endTime":"0","summary":"Verve Therapeutics (VERV – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Whitney Ijem ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/positive-outlook-for-verve-therapeutics-buy-rating-backed-by-fda-clearance-and-promising-developments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/positive-outlook-for-verve-therapeutics-buy-rating-backed-by-fda-clearance-and-promising-developments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VERV"],"gpt_icon":0},{"id":"2522402352","title":"Positive Outlook for Verve Therapeutics: Buy Rating Driven by Promising VERVE-102 Trial Data and Design Improvements","url":"https://stock-news.laohu8.com/highlight/detail?id=2522402352","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522402352?lang=en_us&edition=fundamental","pubTime":"2025-03-25 18:45","pubTimestamp":1742899525,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Mitchell Kapoor has reiterated their bullish stance on VERV stock, giving a Buy rating yesterday. Mitchell Kapoor has given...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/positive-outlook-for-verve-therapeutics-buy-rating-driven-by-promising-verve-102-trial-data-and-design-improvements?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/positive-outlook-for-verve-therapeutics-buy-rating-driven-by-promising-verve-102-trial-data-and-design-improvements?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VERV"],"gpt_icon":0},{"id":"2521744454","title":"Verve Therapeutics Says US FDA Clears Verve-102 IND Application for Premature Coronary Artery Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2521744454","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521744454?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:41","pubTimestamp":1742816496,"startTime":"0","endTime":"0","summary":"Verve Therapeutics (VERV) said Monday its investigational new drug application for Verve-102 has been cleared by the US Food and Drug Administration to treat heterozygous familial hypercholesterolemia","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4539","VERV"],"gpt_icon":0},{"id":"2521745035","title":"Verve Therapeutics Announces Clearance of Investigational New Drug Application by the U.S. FDA for Verve-102, an Investigational Gene Editing Medicine Designed to Durably Lower Cholesterol After a Single Dose","url":"https://stock-news.laohu8.com/highlight/detail?id=2521745035","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521745035?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:01","pubTimestamp":1742814092,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nFWN3Q5087:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VERV","BK4539"],"gpt_icon":0},{"id":"2521467897","title":"Verve Therapeutics Announces Clearance of Investigational New Drug Application by the U.S. FDA for VERVE-102, an Investigational Gene Editing Medicine Designed to Durably Lower Cholesterol After a Single Dose","url":"https://stock-news.laohu8.com/highlight/detail?id=2521467897","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521467897?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:00","pubTimestamp":1742814000,"startTime":"0","endTime":"0","summary":"BOSTON, March  24, 2025  (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced the clearance of its I","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/24/3047698/0/en/Verve-Therapeutics-Announces-Clearance-of-Investigational-New-Drug-Application-by-the-U-S-FDA-for-VERVE-102-an-Investigational-Gene-Editing-Medicine-Designed-to-Durably-Lower-Chole.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","VERV"],"gpt_icon":0},{"id":"2516059676","title":"Verve Therapeutics Is Maintained at Outperform by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2516059676","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516059676?lang=en_us&edition=fundamental","pubTime":"2025-03-04 23:53","pubTimestamp":1741103580,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VERV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 04, 2025 10:53 ET (15:53 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VERV"],"gpt_icon":0},{"id":"2516675389","title":"Verve Therapeutics price target lowered to $15 from $17 at RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2516675389","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516675389?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:41","pubTimestamp":1741092063,"startTime":"0","endTime":"0","summary":"RBC Capital lowered the firm’s price target on Verve Therapeutics (VERV) to $15 from $17 but keeps an Outperform rating on the shares after its Q4 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/verve-therapeutics-price-target-lowered-to-15-from-17-at-rbc-capital?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/verve-therapeutics-price-target-lowered-to-15-from-17-at-rbc-capital?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VERV"],"gpt_icon":0},{"id":"2516662077","title":"RBC Cuts Price Target on Verve Therapeutics to $15 From $17, Keeps Outperform, Speculative Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2516662077","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516662077?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:05","pubTimestamp":1741089925,"startTime":"0","endTime":"0","summary":"Verve Therapeutics (VERV) has an average rating of buy and mean price target of $22.25, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VERV"],"gpt_icon":0},{"id":"2516788796","title":"RBC Capital Keeps Their Buy Rating on Verve Therapeutics (VERV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2516788796","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516788796?lang=en_us&edition=fundamental","pubTime":"2025-03-04 19:51","pubTimestamp":1741089064,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Luca Issi maintained a Buy rating on Verve Therapeutics (VERV – Research Report) yesterday and set a price target of $15.00. Th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-keeps-their-buy-rating-on-verve-therapeutics-verv-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-keeps-their-buy-rating-on-verve-therapeutics-verv-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VERV"],"gpt_icon":0},{"id":"2516665168","title":"Verve Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2516665168","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516665168?lang=en_us&edition=fundamental","pubTime":"2025-03-04 05:05","pubTimestamp":1741035900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nTUACFYJ54:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","VERV","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":82,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VERV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-08-12","symbol":"VERV","fiscalQuarterEnding":"2021/06","expectedEps":-0.53,"name":null,"time":"","type":"earning","dateTimestamp":1628740800000,"reportTimeType":"","actualEps":-2.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VERV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VERV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.6,"hold":0.1,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":10,"updateTime":1744776000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VERV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VERV","date":"2025-05-02","current":-2.457748,"percent":0.878852,"low":-62.162259,"twenty":-14.939571,"median":-6.102709,"eighty":-2.742876,"high":-1.327184,"avg":-9.911598,"sd":10.339975,"marketCap":488376724},"quantilePoints":[{"date":"2021-06-18","current":-32.654395,"twenty":-29.497947,"median":-21.167295,"eighty":-14.940941,"marketCap":1742569153},{"date":"2021-06-25","current":-32.306422,"twenty":-33.28127,"median":-32.654395,"eighty":-22.412565,"marketCap":1723999890},{"date":"2021-07-02","current":-45.008169,"twenty":-46.085349,"median":-33.298325,"eighty":-30.341312,"marketCap":2401815906},{"date":"2021-07-09","current":-41.291898,"twenty":-44.182331,"median":-37.719251,"eighty":-32.445611,"marketCap":2203500832},{"date":"2021-07-16","current":-43.598858,"twenty":-44.860954,"median":-41.51631,"eighty":-32.65883,"marketCap":2326609465},{"date":"2021-07-23","current":-46.938116,"twenty":-46.880666,"median":-42.889715,"eighty":-32.884508,"marketCap":2504805619},{"date":"2021-07-30","current":-53.347337,"twenty":-47.706504,"median":-43.598858,"eighty":-33.28127,"marketCap":2846827270},{"date":"2021-08-06","current":-61.112009,"twenty":-51.440728,"median":-44.909427,"eighty":-34.047863,"marketCap":3261181231},{"date":"2021-08-13","current":-29.159869,"twenty":-53.788981,"median":-45.008169,"eighty":-33.28127,"marketCap":2879507940},{"date":"2021-08-20","current":-30.768522,"twenty":-53.002639,"median":-44.119495,"eighty":-31.587801,"marketCap":3038360794},{"date":"2021-08-27","current":-34.180227,"twenty":-51.440728,"median":-42.943574,"eighty":-31.289512,"marketCap":3375263223},{"date":"2021-09-03","current":-34.695385,"twenty":-49.403063,"median":-41.704816,"eighty":-31.582083,"marketCap":3426134530},{"date":"2021-09-10","current":-35.958979,"twenty":-48.686738,"median":-40.843073,"eighty":-31.68803,"marketCap":3550913208},{"date":"2021-09-17","current":-29.10155,"twenty":-48.45694,"median":-35.6042,"eighty":-31.158293,"marketCap":2873748924},{"date":"2021-09-24","current":-23.293876,"twenty":-47.7083,"median":-34.712395,"eighty":-30.238785,"marketCap":2300246926},{"date":"2021-10-01","current":-24.110352,"twenty":-47.589809,"median":-34.243407,"eighty":-29.159869,"marketCap":2380873148},{"date":"2021-10-08","current":-21.354744,"twenty":-47.103283,"median":-34.027137,"eighty":-25.692351,"marketCap":2108759648},{"date":"2021-10-15","current":-21.349884,"twenty":-46.909391,"median":-33.383602,"eighty":-24.247403,"marketCap":2108279730},{"date":"2021-10-22","current":-20.761827,"twenty":-46.605986,"median":-32.917417,"eighty":-23.323036,"marketCap":2050209653},{"date":"2021-10-29","current":-22.545439,"twenty":-45.812463,"median":-32.306422,"eighty":-22.932294,"marketCap":2226339555},{"date":"2021-11-05","current":-26.136963,"twenty":-45.525215,"median":-31.587429,"eighty":-23.25694,"marketCap":2580998950},{"date":"2021-11-12","current":-20.667105,"twenty":-44.968672,"median":-31.108721,"eighty":-22.843842,"marketCap":2325214652},{"date":"2021-11-19","current":-17.682856,"twenty":-44.776575,"median":-30.600853,"eighty":-22.274252,"marketCap":1989462713},{"date":"2021-11-26","current":-14.193382,"twenty":-44.640132,"median":-30.158595,"eighty":-21.777562,"marketCap":1596868981},{"date":"2021-12-03","current":-13.675313,"twenty":-43.598858,"median":-29.159869,"eighty":-21.369324,"marketCap":1538582059},{"date":"2021-12-10","current":-13.983585,"twenty":-43.266728,"median":-28.931451,"eighty":-21.087446,"marketCap":1573265186},{"date":"2021-12-17","current":-16.813698,"twenty":-42.943574,"median":-26.642401,"eighty":-20.667105,"marketCap":1891675562},{"date":"2021-12-23","current":-17.691419,"twenty":-42.8574,"median":-26.136963,"eighty":-17.715396,"marketCap":1990426133},{"date":"2021-12-31","current":-15.786123,"twenty":-42.08183,"median":-25.274317,"eighty":-17.274395,"marketCap":1776065138},{"date":"2022-01-07","current":-13.72241,"twenty":-41.591713,"median":-24.46513,"eighty":-16.775164,"marketCap":1543880870},{"date":"2022-01-14","current":-14.039245,"twenty":-41.33678,"median":-24.246431,"eighty":-15.710768,"marketCap":1579527417},{"date":"2022-01-21","current":-13.923643,"twenty":-40.753308,"median":-24.188111,"eighty":-15.395644,"marketCap":1566521245},{"date":"2022-01-28","current":-12.176765,"twenty":-37.733087,"median":-23.439675,"eighty":-14.983072,"marketCap":1369983524},{"date":"2022-02-04","current":-11.551657,"twenty":-35.746112,"median":-23.279296,"eighty":-14.684049,"marketCap":1299653849},{"date":"2022-02-11","current":-13.247156,"twenty":-35.268232,"median":-22.851618,"eighty":-14.251611,"marketCap":1490411049},{"date":"2022-02-18","current":-11.457463,"twenty":-34.855344,"median":-22.538149,"eighty":-14.189957,"marketCap":1289056227},{"date":"2022-02-25","current":-13.170088,"twenty":-34.715796,"median":-22.29758,"eighty":-14.064935,"marketCap":1481740267},{"date":"2022-03-04","current":-11.838522,"twenty":-34.561249,"median":-22.030281,"eighty":-13.877402,"marketCap":1331928426},{"date":"2022-03-11","current":-11.247666,"twenty":-34.31339,"median":-21.692513,"eighty":-13.701858,"marketCap":1265452432},{"date":"2022-03-18","current":-10.085637,"twenty":-34.218135,"median":-21.369324,"eighty":-13.587969,"marketCap":1213443343},{"date":"2022-03-25","current":-9.443677,"twenty":-34.129683,"median":-21.228995,"eighty":-13.23945,"marketCap":1136206557},{"date":"2022-04-01","current":-9.088378,"twenty":-34.032483,"median":-20.922206,"eighty":-13.160668,"marketCap":1093459153},{"date":"2022-04-08","current":-7.917508,"twenty":-33.982912,"median":-20.714466,"eighty":-12.679421,"marketCap":952587027},{"date":"2022-04-14","current":-8.208207,"twenty":-33.842055,"median":-19.47469,"eighty":-12.374573,"marketCap":987562176},{"date":"2022-04-22","current":-6.665887,"twenty":-33.349491,"median":-17.691419,"eighty":-12.192179,"marketCap":801999583},{"date":"2022-04-29","current":-6.034246,"twenty":-33.204309,"median":-17.492326,"eighty":-11.914733,"marketCap":726004260},{"date":"2022-05-06","current":-5.334565,"twenty":-33.068577,"median":-16.852232,"eighty":-11.563646,"marketCap":641822801},{"date":"2022-05-13","current":-4.869088,"twenty":-32.663265,"median":-16.76232,"eighty":-11.392383,"marketCap":668121653},{"date":"2022-05-20","current":-4.755606,"twenty":-32.5848,"median":-16.150056,"eighty":-10.105824,"marketCap":652549990},{"date":"2022-05-27","current":-5.54998,"twenty":-32.241841,"median":-15.409346,"eighty":-9.616481,"marketCap":761551629},{"date":"2022-06-03","current":-5.170525,"twenty":-31.983517,"median":-15.39436,"eighty":-9.354852,"marketCap":709483882},{"date":"2022-06-10","current":-4.471901,"twenty":-31.614158,"median":-15.302306,"eighty":-9.088378,"marketCap":613620834},{"date":"2022-06-17","current":-4.486086,"twenty":-31.560699,"median":-14.940941,"eighty":-8.446418,"marketCap":615567291},{"date":"2022-06-24","current":-5.993269,"twenty":-31.397404,"median":-14.839897,"eighty":-8.028942,"marketCap":822378437},{"date":"2022-07-01","current":-5.542888,"twenty":-31.158293,"median":-14.347518,"eighty":-7.642151,"marketCap":760578400},{"date":"2022-07-08","current":-7.528823,"twenty":-30.94251,"median":-14.261887,"eighty":-7.437047,"marketCap":1033082498},{"date":"2022-07-15","current":-8.408309,"twenty":-30.793794,"median":-14.208367,"eighty":-7.437047,"marketCap":1153762884},{"date":"2022-07-22","current":-12.715115,"twenty":-30.567319,"median":-14.184819,"eighty":-7.498573,"marketCap":1744729900},{"date":"2022-07-29","current":-10.451203,"twenty":-30.287385,"median":-14.071357,"eighty":-7.594882,"marketCap":1434082747},{"date":"2022-08-05","current":-11.321429,"twenty":-30.152277,"median":-13.979303,"eighty":-7.641344,"marketCap":1553492562},{"date":"2022-08-12","current":-17.039792,"twenty":-29.572967,"median":-13.981444,"eighty":-7.645381,"marketCap":2133347845},{"date":"2022-08-19","current":-16.029565,"twenty":-29.177365,"median":-14.103469,"eighty":-7.782487,"marketCap":2006869509},{"date":"2022-08-26","current":-18.777764,"twenty":-29.159869,"median":-14.1891,"eighty":-7.899631,"marketCap":2350938535},{"date":"2022-09-02","current":-17.595177,"twenty":-29.124878,"median":-14.210508,"eighty":-7.970802,"marketCap":2202880958},{"date":"2022-09-09","current":-18.552738,"twenty":-28.96547,"median":-14.261887,"eighty":-8.017637,"marketCap":2322765636},{"date":"2022-09-16","current":-17.499421,"twenty":-28.21427,"median":-14.469542,"eighty":-8.09758,"marketCap":2190892490},{"date":"2022-09-23","current":-16.854037,"twenty":-27.093149,"median":-14.934092,"eighty":-8.198517,"marketCap":2110091673},{"date":"2022-09-30","current":-16.498608,"twenty":-26.578249,"median":-14.95128,"eighty":-8.288248,"marketCap":2065592732},{"date":"2022-10-07","current":-16.090346,"twenty":-26.343998,"median":-15.287456,"eighty":-8.423553,"marketCap":2014479084},{"date":"2022-10-14","current":-14.678238,"twenty":-25.973668,"median":-15.294881,"eighty":-8.459338,"marketCap":1837685994},{"date":"2022-10-21","current":-15.369882,"twenty":-25.549878,"median":-15.302306,"eighty":-8.480333,"marketCap":1924278528},{"date":"2022-10-28","current":-19.548569,"twenty":-25.275775,"median":-15.343465,"eighty":-8.522485,"marketCap":2447441752},{"date":"2022-11-04","current":-15.028863,"twenty":-25.226203,"median":-15.387938,"eighty":-8.690928,"marketCap":1881583598},{"date":"2022-11-11","current":-11.266009,"twenty":-24.885032,"median":-15.309677,"eighty":-8.584128,"marketCap":1663302276},{"date":"2022-11-18","current":-9.768047,"twenty":-24.38737,"median":-15.287456,"eighty":-8.694003,"marketCap":1442144677},{"date":"2022-11-25","current":-9.304889,"twenty":-24.266843,"median":-15.048075,"eighty":-8.868577,"marketCap":1373764472},{"date":"2022-12-02","current":-10.01423,"twenty":-24.249347,"median":-14.98639,"eighty":-8.955101,"marketCap":1478490912},{"date":"2022-12-09","current":-9.03367,"twenty":-24.240599,"median":-14.940941,"eighty":-8.928396,"marketCap":1333722010},{"date":"2022-12-16","current":-8.040592,"twenty":-24.217271,"median":-14.796025,"eighty":-8.868577,"marketCap":1187104994},{"date":"2022-12-23","current":-7.598297,"twenty":-24.13368,"median":-14.591567,"eighty":-8.50262,"marketCap":1121804979},{"date":"2022-12-30","current":-8.073973,"twenty":-24.110352,"median":-14.330392,"eighty":-8.408309,"marketCap":1192033297},{"date":"2023-01-06","current":-8.528786,"twenty":-23.57381,"median":-14.236197,"eighty":-8.324328,"marketCap":1259181426},{"date":"2023-01-13","current":-9.571935,"twenty":-23.377467,"median":-14.199804,"eighty":-8.39652,"marketCap":1413190896},{"date":"2023-01-20","current":-9.008634,"twenty":-23.321092,"median":-14.180537,"eighty":-8.415502,"marketCap":1330025782},{"date":"2023-01-27","current":-9.35496,"twenty":-23.27638,"median":-14.039245,"eighty":-8.43597,"marketCap":1381156926},{"date":"2023-02-03","current":-9.717976,"twenty":-23.258884,"median":-13.951473,"eighty":-8.450775,"marketCap":1434752222},{"date":"2023-02-10","current":-8.532959,"twenty":-23.012969,"median":-13.782352,"eighty":-8.468702,"marketCap":1259797464},{"date":"2023-02-17","current":-8.804177,"twenty":-22.845786,"median":-13.705284,"eighty":-8.481141,"marketCap":1299839926},{"date":"2023-02-24","current":-7.769373,"twenty":-22.723314,"median":-13.652144,"eighty":-8.430746,"marketCap":1147062532},{"date":"2023-03-03","current":-7.649257,"twenty":-22.539607,"median":-13.611089,"eighty":-8.272588,"marketCap":1203893669},{"date":"2023-03-10","current":-6.710288,"twenty":-22.453099,"median":-13.493526,"eighty":-8.148245,"marketCap":1056112166},{"date":"2023-03-17","current":-6.474564,"twenty":-22.305356,"median":-13.247156,"eighty":-8.017637,"marketCap":1019012207},{"date":"2023-03-24","current":-5.665244,"twenty":-22.206212,"median":-13.178651,"eighty":-7.921708,"marketCap":891635681},{"date":"2023-03-31","current":-5.665244,"twenty":-22.088601,"median":-13.157243,"eighty":-7.889544,"marketCap":891635681},{"date":"2023-04-06","current":-5.24094,"twenty":-21.979737,"median":-12.934602,"eighty":-7.787733,"marketCap":824855755},{"date":"2023-04-14","current":-6.164194,"twenty":-21.772702,"median":-12.704975,"eighty":-7.643766,"marketCap":970163927},{"date":"2023-04-21","current":-6.223125,"twenty":-21.728963,"median":-12.641626,"eighty":-7.541049,"marketCap":979438917},{"date":"2023-04-28","current":-6.183837,"twenty":-21.601631,"median":-12.414392,"eighty":-7.449107,"marketCap":973255591},{"date":"2023-05-05","current":-6.416544,"twenty":-21.458748,"median":-12.339465,"eighty":-7.283557,"marketCap":1009880688},{"date":"2023-05-12","current":-7.140422,"twenty":-21.366408,"median":-12.2153,"eighty":-7.056792,"marketCap":1123809594},{"date":"2023-05-19","current":-5.645987,"twenty":-21.353772,"median":-12.005503,"eighty":-6.84703,"marketCap":1011738224},{"date":"2023-05-26","current":-5.484703,"twenty":-21.301528,"median":-11.932716,"eighty":-6.700859,"marketCap":982836796},{"date":"2023-06-02","current":-5.325726,"twenty":-21.108106,"median":-11.766756,"eighty":-6.635642,"marketCap":954348773},{"date":"2023-06-09","current":-6.079138,"twenty":-21.087446,"median":-11.594473,"eighty":-6.416544,"marketCap":1089357231},{"date":"2023-06-16","current":-6.856742,"twenty":-20.922206,"median":-11.547376,"eighty":-6.377203,"marketCap":1228700822},{"date":"2023-06-23","current":-6.44202,"twenty":-20.820883,"median":-11.495572,"eighty":-6.386645,"marketCap":1154384240},{"date":"2023-06-30","current":-6.486948,"twenty":-20.775317,"median":-11.413579,"eighty":-6.384285,"marketCap":1162435203},{"date":"2023-07-07","current":-6.421284,"twenty":-20.723938,"median":-11.293719,"eighty":-6.391554,"marketCap":1150668411},{"date":"2023-07-14","current":-7.036455,"twenty":-20.346101,"median":-11.243385,"eighty":-6.401592,"marketCap":1260904674},{"date":"2023-07-21","current":-6.853286,"twenty":-19.830124,"median":-11.037127,"eighty":-6.413167,"marketCap":1228081517},{"date":"2023-07-28","current":-6.725414,"twenty":-19.745125,"median":-10.451203,"eighty":-6.41844,"marketCap":1205167238},{"date":"2023-08-04","current":-6.538789,"twenty":-19.636542,"median":-10.136105,"eighty":-6.422166,"marketCap":1171724776},{"date":"2023-08-11","current":-5.966628,"twenty":-19.456656,"median":-10.018403,"eighty":-6.401592,"marketCap":1146982734},{"date":"2023-08-18","current":-4.829654,"twenty":-19.292947,"median":-9.773418,"eighty":-6.367993,"marketCap":928418801},{"date":"2023-08-25","current":-4.425249,"twenty":-19.23598,"median":-9.717976,"eighty":-6.300434,"marketCap":850678861},{"date":"2023-09-01","current":-4.266139,"twenty":-19.174195,"median":-9.705786,"eighty":-6.25816,"marketCap":820092654},{"date":"2023-09-08","current":-4.173325,"twenty":-19.114826,"median":-9.685396,"eighty":-6.236766,"marketCap":802250701},{"date":"2023-09-15","current":-4.279398,"twenty":-19.0229,"median":-9.601139,"eighty":-6.205112,"marketCap":822641505},{"date":"2023-09-22","current":-4.126917,"twenty":-18.777764,"median":-9.571935,"eighty":-6.17598,"marketCap":793329724},{"date":"2023-09-29","current":-4.295972,"twenty":-18.642748,"median":-9.496828,"eighty":-6.102833,"marketCap":825827568},{"date":"2023-10-06","current":-4.00427,"twenty":-18.530714,"median":-9.463447,"eighty":-6.065314,"marketCap":769752857},{"date":"2023-10-13","current":-3.815327,"twenty":-18.44166,"median":-9.432153,"eighty":-6.005773,"marketCap":733431737},{"date":"2023-10-20","current":-3.193803,"twenty":-18.423467,"median":-9.417549,"eighty":-5.961324,"marketCap":613954369},{"date":"2023-10-23","current":-3.076128,"twenty":-18.409103,"median":-9.417549,"eighty":-5.948537,"marketCap":591333320},{"date":"2023-11-02","current":-3.894882,"twenty":-18.366013,"median":-9.409204,"eighty":-5.912754,"marketCap":748724840},{"date":"2023-11-10","current":-5.303884,"twenty":-18.188865,"median":-9.371259,"eighty":-5.806678,"marketCap":1022594077},{"date":"2023-11-17","current":-3.630713,"twenty":-18.181204,"median":-9.354906,"eighty":-5.783302,"marketCap":700005173},{"date":"2023-11-24","current":-4.007673,"twenty":-18.177374,"median":-9.354852,"eighty":-5.751026,"marketCap":772683305},{"date":"2023-12-01","current":-4.594669,"twenty":-18.15535,"median":-9.317619,"eighty":-5.676693,"marketCap":885856819},{"date":"2023-12-08","current":-5.385214,"twenty":-18.119031,"median":-9.225609,"eighty":-5.662887,"marketCap":1038274679},{"date":"2023-12-15","current":-5.973375,"twenty":-17.983092,"median":-9.196401,"eighty":-5.647293,"marketCap":1151672610},{"date":"2023-12-22","current":-5.877434,"twenty":-17.786329,"median":-9.112949,"eighty":-5.647293,"marketCap":1133175075},{"date":"2023-12-29","current":-6.23617,"twenty":-17.771426,"median":-9.090397,"eighty":-5.647529,"marketCap":1202339771},{"date":"2024-01-05","current":-5.677209,"twenty":-17.741404,"median":-9.083741,"eighty":-5.647372,"marketCap":1094571524},{"date":"2024-01-12","current":-5.426928,"twenty":-17.703407,"median":-9.07331,"eighty":-5.646676,"marketCap":1046317085},{"date":"2024-01-19","current":-5.139104,"twenty":-17.687994,"median":-9.060792,"eighty":-5.637742,"marketCap":990824480},{"date":"2024-01-26","current":-4.943051,"twenty":-17.67943,"median":-9.008634,"eighty":-5.556573,"marketCap":953025170},{"date":"2024-02-02","current":-4.676085,"twenty":-17.646476,"median":-8.931885,"eighty":-5.540349,"marketCap":901553768},{"date":"2024-02-09","current":-4.926366,"twenty":-17.600923,"median":-8.854204,"eighty":-5.489345,"marketCap":949808207},{"date":"2024-02-16","current":-5.539554,"twenty":-17.558087,"median":-8.808349,"eighty":-5.424425,"marketCap":1068031583},{"date":"2024-02-23","current":-5.55624,"twenty":-17.501847,"median":-8.739502,"eighty":-5.431099,"marketCap":1071248545},{"date":"2024-03-01","current":-7.126121,"twenty":-17.490421,"median":-8.587202,"eighty":-5.450287,"marketCap":1425708706},{"date":"2024-03-08","current":-6.244237,"twenty":-17.443314,"median":-8.530873,"eighty":-5.463635,"marketCap":1249272028},{"date":"2024-03-15","current":-5.684178,"twenty":-17.398877,"median":-8.482756,"eighty":-5.478528,"marketCap":1137222194},{"date":"2024-03-22","current":-5.521176,"twenty":-17.391734,"median":-8.450048,"eighty":-5.478528,"marketCap":1104610675},{"date":"2024-03-28","current":-5.512817,"twenty":-17.363164,"median":-8.414303,"eighty":-5.460298,"marketCap":1102938290},{"date":"2024-04-05","current":-3.627843,"twenty":-17.31036,"median":-8.345192,"eighty":-5.426928,"marketCap":725815341},{"date":"2024-04-12","current":-3.372891,"twenty":-17.293545,"median":-8.200132,"eighty":-5.385214,"marketCap":674807581},{"date":"2024-04-19","current":-2.783576,"twenty":-17.276708,"median":-8.144907,"eighty":-5.349918,"marketCap":556904398},{"date":"2024-04-26","current":-2.609113,"twenty":-17.156631,"median":-8.037593,"eighty":-5.335158,"marketCap":521999934},{"date":"2024-05-03","current":-2.57975,"twenty":-17.130534,"median":-7.969658,"eighty":-5.31947,"marketCap":516125336},{"date":"2024-05-10","current":-2.713119,"twenty":-17.058943,"median":-7.92205,"eighty":-5.252726,"marketCap":534020535},{"date":"2024-05-17","current":-2.721651,"twenty":-17.039792,"median":-7.898724,"eighty":-5.220173,"marketCap":535699845},{"date":"2024-05-24","current":-2.27373,"twenty":-17.035004,"median":-7.879511,"eighty":-5.172475,"marketCap":447536077},{"date":"2024-05-31","current":-2.192678,"twenty":-17.023514,"median":-7.815272,"eighty":-5.164385,"marketCap":431582634},{"date":"2024-06-07","current":-2.252401,"twenty":-17.00915,"median":-7.649257,"eighty":-5.113676,"marketCap":443337803},{"date":"2024-06-14","current":-2.38891,"twenty":-16.914933,"median":-7.642959,"eighty":-5.054805,"marketCap":470206760},{"date":"2024-06-21","current":-2.188412,"twenty":-16.853315,"median":-7.598297,"eighty":-5.000761,"marketCap":430742979},{"date":"2024-06-28","current":-2.030573,"twenty":-16.852593,"median":-7.589952,"eighty":-4.980279,"marketCap":399675746},{"date":"2024-07-05","current":-2.192678,"twenty":-16.829112,"median":-7.514845,"eighty":-4.961403,"marketCap":431582634},{"date":"2024-07-12","current":-2.717385,"twenty":-16.795715,"median":-7.475676,"eighty":-4.926252,"marketCap":534860190},{"date":"2024-07-15","current":-2.870958,"twenty":-16.789721,"median":-7.453197,"eighty":-4.924469,"marketCap":565087767},{"date":"2024-08-02","current":-2.870958,"twenty":-16.783727,"median":-7.450641,"eighty":-4.918023,"marketCap":565087767},{"date":"2024-08-09","current":-2.389593,"twenty":-16.740912,"median":-7.389961,"eighty":-4.826532,"marketCap":460357437},{"date":"2024-08-16","current":-1.994256,"twenty":-16.733959,"median":-7.296883,"eighty":-4.801708,"marketCap":384195361},{"date":"2024-08-23","current":-2.126035,"twenty":-16.609079,"median":-7.195432,"eighty":-4.755606,"marketCap":409582720},{"date":"2024-08-30","current":-2.692685,"twenty":-16.561048,"median":-7.149294,"eighty":-4.718312,"marketCap":518748362},{"date":"2024-09-06","current":-2.429126,"twenty":-16.511096,"median":-7.124489,"eighty":-4.649992,"marketCap":467973645},{"date":"2024-09-13","current":-2.481838,"twenty":-16.497212,"median":-7.057192,"eighty":-4.594267,"marketCap":478128588},{"date":"2024-09-20","current":-2.363237,"twenty":-16.471361,"median":-7.034442,"eighty":-4.512568,"marketCap":455279966},{"date":"2024-09-27","current":-2.178746,"twenty":-16.434247,"median":-7.001895,"eighty":-4.45243,"marketCap":419737663},{"date":"2024-10-04","current":-2.073323,"twenty":-16.227702,"median":-6.929319,"eighty":-4.356537,"marketCap":399427776},{"date":"2024-10-11","current":-2.020612,"twenty":-16.165511,"median":-6.877479,"eighty":-4.305916,"marketCap":389272833},{"date":"2024-10-18","current":-2.398378,"twenty":-16.152523,"median":-6.863399,"eighty":-4.276746,"marketCap":462049928},{"date":"2024-10-25","current":-2.512587,"twenty":-16.102288,"median":-6.853286,"eighty":-4.248902,"marketCap":484052305},{"date":"2024-10-31","current":-2.543335,"twenty":-16.064409,"median":-6.836006,"eighty":-4.196586,"marketCap":489976022},{"date":"2024-11-08","current":-2.732949,"twenty":-16.036586,"median":-6.820277,"eighty":-4.165088,"marketCap":538462022},{"date":"2024-11-15","current":-2.311834,"twenty":-15.910413,"median":-6.725414,"eighty":-4.125591,"marketCap":455491459},{"date":"2024-11-22","current":-1.976661,"twenty":-15.804065,"median":-6.707483,"eighty":-4.019554,"marketCap":389453664},{"date":"2024-11-29","current":-2.410667,"twenty":-15.740665,"median":-6.694678,"eighty":-3.996315,"marketCap":474964142},{"date":"2024-12-06","current":-2.625522,"twenty":-15.671678,"median":-6.665887,"eighty":-3.89886,"marketCap":517296062},{"date":"2024-12-13","current":-2.677087,"twenty":-15.659751,"median":-6.628019,"eighty":-3.827586,"marketCap":527455723},{"date":"2024-12-20","current":-2.217298,"twenty":-15.603312,"median":-6.573349,"eighty":-3.714001,"marketCap":436865414},{"date":"2024-12-27","current":-2.707167,"twenty":-15.538951,"median":-6.557068,"eighty":-3.628417,"marketCap":533382192},{"date":"2025-01-03","current":-2.582551,"twenty":-15.523581,"median":-6.538789,"eighty":-3.560971,"marketCap":508829678},{"date":"2025-01-10","current":-2.582551,"twenty":-15.432193,"median":-6.474564,"eighty":-3.367876,"marketCap":508829678},{"date":"2025-01-17","current":-2.621225,"twenty":-15.409346,"median":-6.432755,"eighty":-3.08703,"marketCap":516449424},{"date":"2025-01-24","current":-3.433375,"twenty":-15.404208,"median":-6.418914,"eighty":-3.076481,"marketCap":676464081},{"date":"2025-01-31","current":-3.184143,"twenty":-15.393076,"median":-6.395376,"eighty":-3.084451,"marketCap":627359054},{"date":"2025-02-07","current":-3.592367,"twenty":-15.377104,"median":-6.374177,"eighty":-3.105077,"marketCap":707789702},{"date":"2025-02-14","current":-3.313056,"twenty":-15.338182,"median":-6.353599,"eighty":-3.152028,"marketCap":652758206},{"date":"2025-02-21","current":-3.364621,"twenty":-15.311151,"median":-6.327828,"eighty":-3.179529,"marketCap":662917867},{"date":"2025-02-28","current":-2.641631,"twenty":-15.302306,"median":-6.296207,"eighty":-3.081873,"marketCap":524915808},{"date":"2025-03-07","current":-2.953767,"twenty":-15.296366,"median":-6.267048,"eighty":-3.015698,"marketCap":586940026},{"date":"2025-03-14","current":-2.74821,"twenty":-15.283923,"median":-6.253996,"eighty":-2.947346,"marketCap":546093973},{"date":"2025-03-21","current":-2.475623,"twenty":-15.186404,"median":-6.244237,"eighty":-2.887812,"marketCap":491928554},{"date":"2025-03-28","current":-2.359438,"twenty":-15.04039,"median":-6.236318,"eighty":-2.869701,"marketCap":468841655},{"date":"2025-04-04","current":-1.71819,"twenty":-15.021782,"median":-6.213689,"eighty":-2.823583,"marketCap":341419727},{"date":"2025-04-11","current":-1.362933,"twenty":-14.991344,"median":-6.203518,"eighty":-2.777216,"marketCap":270827092},{"date":"2025-04-17","current":-2.015354,"twenty":-14.957484,"median":-6.183646,"eighty":-2.758732,"marketCap":400468913},{"date":"2025-04-25","current":-2.58287,"twenty":-14.940941,"median":-6.17598,"eighty":-2.754435,"marketCap":513239539},{"date":"2025-05-02","current":-2.457748,"twenty":-14.939571,"median":-6.102709,"eighty":-2.742876,"marketCap":488376724}],"updateTime":1746443195283}}}